Last quarter (Q3 2023), PROCEPT BioRobotics's total revenue was $35.10M, an increase of 72.50% from the same quarter last year. In Q3, PROCEPT BioRobotics's net income was $-24.62M. See PROCEPT BioRobotics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 116.39M	$ 75.01M	$ 34.47M	$ 7.72M	$ 6.17M
Cost of Revenue	$ 17.42M	$ -37.93M	$ -18.61M	$ 8.97M	$ 8.05M
Gross Profit	$ 75.14M	$ 37.09M	$ 15.87M	$ -1.25M	$ -1.89M
Operating Expense	$ 98.06M	$ -117.81M	$ -70.03M	$ 46.55M	$ 41.66M
Operating Income	$ -104.65M	$ -80.72M	$ -54.16M	$ -47.80M	$ -43.55M
Net Non Operating Interest Income Expense	$ -3.74M	$ -5.18M	$ -5.81M	$ -5.08M	$ 425.00K
Other Income Expense	$ 3.22M	$ 3.26M	$ 19.00K	$ -140.00K	$ 1.15M
Pretax Income	$ -111.64M	$ -89.17M	$ -59.97M	$ -53.02M	$ -41.98M
Tax Provision	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -106.56M	$ -87.15M	$ -59.85M	$ -53.02M	$ -41.98M
Basic EPS	$ -2.33	$ -1.96	$ -3.63	$ -1.58	$ -1.25
Diluted EPS	$ -2.33	$ -1.96	$ -3.63	$ -1.58	$ -1.25
Basic Average Shares	$ 182.94M	$ 44.40M	$ 16.48M	$ 33.59M	$ 33.59M
Diluted Average Shares	$ 182.94M	$ 44.40M	$ 16.48M	$ 33.59M	$ 33.59M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 115.48M	$ -155.74M	$ -88.64M	$ 55.52M	$ 49.72M
Net Income From Continuing And Discontinued Operation	$ -106.56M	$ -87.15M	$ -59.85M	$ -53.02M	$ -41.98M
Normalized Income	$ -42.04M	-	-	$ -52.90M	$ -43.17M
Interest Expense	-	-	-	$ 5.26M	$ 724.00K
EBIT	$ -107.91M	$ -83.98M	$ -54.16M	$ -47.76M	$ -41.25M
EBITDA	$ -80.20M	$ -81.14M	$ -50.84M	$ -44.90M	$ -39.76M

Currency in USD

PROCEPT BioRobotics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing